Catalent
CTLT
#1855
Rank
ยฃ8.45 B
Marketcap
ยฃ46.59
Share price
0.00%
Change (1 day)
11.54%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -ยฃ5.08

According to Catalent's latest financial reports the company's current EPS (TTM) is -ยฃ4.65. In 2023 the company made an earnings per share (EPS) of -ยฃ4.99 a decrease over its 2022 EPS that were of ยฃ1.67.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-ยฃ5.081.85%
2023-ยฃ4.99-399.56%
2022ยฃ1.67-30.58%
2021ยฃ2.4079.67%
2020ยฃ1.34114.12%
2019ยฃ0.62-15%
2018ยฃ0.7375.44%
2017ยฃ0.42-22.97%
2016ยฃ0.54-59.56%
2015ยฃ1.34282.05%
2014ยฃ0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-ยฃ0.50-89.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-ยฃ4.25-8.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-ยฃ0.55-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-ยฃ1.09-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA